vs
Ambiq Micro, Inc.（AMBQ）与Assertio Holdings, Inc.（ASRT）财务数据对比。点击上方公司名可切换其他公司
Ambiq Micro, Inc.的季度营收约是Assertio Holdings, Inc.的1.3倍（$18.2M vs $13.5M）
Ambiq Micro, Inc.是一家专注于低功耗微控制器与片上系统的美国半导体企业，产品应用于智能手表、医疗设备、传感器等多个领域。公司由密歇根大学研究人员于2010年创立，总部位于得克萨斯州奥斯汀。其产品采用亚阈值功率优化技术（SPOT）降低能耗，可支持设备端边缘人工智能运算。
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
AMBQ vs ASRT — 直观对比
营收规模更大
AMBQ
是对方的1.3倍
$13.5M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.2M | $13.5M |
| 净利润 | $-9.0M | — |
| 毛利率 | 42.3% | — |
| 营业利润率 | -55.3% | -86.7% |
| 净利率 | -49.6% | — |
| 营收同比 | — | -57.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.72 | $-4.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMBQASRT
| Q4 25 | — | $13.5M | ||
| Q3 25 | $18.2M | $49.5M | ||
| Q2 25 | $17.9M | $29.2M | ||
| Q1 25 | — | $26.5M | ||
| Q4 24 | — | $32.2M | ||
| Q3 24 | — | $29.2M | ||
| Q2 24 | — | $31.1M | ||
| Q1 24 | — | $32.4M |
净利润AMBQASRT
| Q4 25 | — | — | ||
| Q3 25 | $-9.0M | $11.4M | ||
| Q2 25 | $-8.5M | $-16.4M | ||
| Q1 25 | — | $-13.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-2.9M | ||
| Q2 24 | — | $-3.7M | ||
| Q1 24 | — | $-4.5M |
毛利率AMBQASRT
| Q4 25 | — | — | ||
| Q3 25 | 42.3% | — | ||
| Q2 25 | 40.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率AMBQASRT
| Q4 25 | — | -86.7% | ||
| Q3 25 | -55.3% | 23.2% | ||
| Q2 25 | -49.2% | -27.5% | ||
| Q1 25 | — | -50.0% | ||
| Q4 24 | — | -41.9% | ||
| Q3 24 | — | -10.4% | ||
| Q2 24 | — | -11.6% | ||
| Q1 24 | — | -13.4% |
净利率AMBQASRT
| Q4 25 | — | — | ||
| Q3 25 | -49.6% | 23.1% | ||
| Q2 25 | -47.5% | -56.0% | ||
| Q1 25 | — | -51.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -10.0% | ||
| Q2 24 | — | -11.8% | ||
| Q1 24 | — | -13.9% |
每股收益（稀释后）AMBQASRT
| Q4 25 | — | $-4.54 | ||
| Q3 25 | $-0.72 | $0.11 | ||
| Q2 25 | $-18.89 | $-0.17 | ||
| Q1 25 | — | $-0.14 | ||
| Q4 24 | — | $-3.28 | ||
| Q3 24 | — | $-0.03 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.5M | $63.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $169.8M | $94.0M |
| 总资产 | $186.7M | $267.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMBQASRT
| Q4 25 | — | $63.4M | ||
| Q3 25 | $146.5M | $93.4M | ||
| Q2 25 | $47.5M | $98.2M | ||
| Q1 25 | — | $87.3M | ||
| Q4 24 | — | $100.1M | ||
| Q3 24 | — | $88.6M | ||
| Q2 24 | — | $88.4M | ||
| Q1 24 | — | $80.7M |
总债务AMBQASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $38.6M |
股东权益AMBQASRT
| Q4 25 | — | $94.0M | ||
| Q3 25 | $169.8M | $105.8M | ||
| Q2 25 | $-307.3M | $93.3M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $121.1M | ||
| Q3 24 | — | $130.5M | ||
| Q2 24 | — | $132.2M | ||
| Q1 24 | — | $134.5M |
总资产AMBQASRT
| Q4 25 | — | $267.0M | ||
| Q3 25 | $186.7M | $319.8M | ||
| Q2 25 | $89.2M | $273.8M | ||
| Q1 25 | — | $286.4M | ||
| Q4 24 | — | $284.7M | ||
| Q3 24 | — | $276.0M | ||
| Q2 24 | — | $279.4M | ||
| Q1 24 | — | $282.0M |
负债/权益比AMBQASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.0M | $-30.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMBQASRT
| Q4 25 | — | $-30.0M | ||
| Q3 25 | $-5.0M | $-4.8M | ||
| Q2 25 | $-10.5M | $19.1M | ||
| Q1 25 | — | $-12.5M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | — | $-35.0K | ||
| Q2 24 | — | $7.4M | ||
| Q1 24 | — | $7.5M |
资本支出强度AMBQASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率AMBQASRT
| Q4 25 | — | — | ||
| Q3 25 | — | -0.42× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMBQ
| Customer Concentration Risk | $16.2M | 89% |
| Other | $2.0M | 11% |
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
